(0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Urban Net Kanda Conference

Apr 18, 2016 10:00 AM - Apr 19, 2016 5:30 PM

3-6-2 Uchi Kanda,, Chiyoda-ku,, Tokyo, 101-0047 Japan

5th DIA FDA IND/NDA Training Course

Overview

We've closed online registration.

Onsite resistration is still available.

Who should attend?

This training will be fit for regulatory and clinical development professionals in Japan who are intending/planning US submissions and clinical trials or similar projects.

Program Committee

  • Masayoshi Higuchi
    Masayoshi Higuchi Head of Quality & Regulatory Compliance Unit,
    Chugai Pharmaceutical Co., Ltd., Japan
  • Akiko Ikeda, RPh
    Akiko Ikeda, RPh Associate Director, Regulatory Development Dept.
    Janssen Pharmaceutical K.K., Japan
  • Yumi Inukai
    Yumi Inukai New Drug Regulatory Affairs Dept.
    Daiichi Sankyo Co., Ltd., Japan
  • Miyuki Kaneko
    Miyuki Kaneko Japan Regulatory Portfolio Lead, Regulatory Affairs
    Pfizer R&D Japan G.K., Japan
  • Yomei Matsuoka, MSc, RPh
    Yomei Matsuoka, MSc, RPh Vice President, Pharmacoepidemiology and PMS Department
    Daiichi Sankyo Co., Ltd., Japan
  • Miwa Tamada
    Miwa Tamada Manager, New Drug RA Department, Regulatory Affairs
    GlaxoSmithKline K.K., Japan

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.